{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:47Z","timestamp":1793377907696,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.058","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:59:01Z","timestamp":1787198341000},"page":"5630-5631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A renewed role for DNA vaccines for tuberculosis"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-4004","authenticated-orcid":false,"given":"Claudio","family":"Counoupas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warwick J.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.058_bib1","series-title":"Global Tuberculosis Report 2025","year":"2025"},{"key":"10.1016\/j.ymthe.2026.07.058_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.058_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.058_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","article-title":"Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis","volume":"67","author":"Kamath","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.07.058_bib5","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/IAI.70.4.1949-1956.2002","article-title":"Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis","volume":"70","author":"Palendira","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.07.058_bib6","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/IAI.00322-07","article-title":"Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis","volume":"75","author":"Triccas","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.07.058_bib7","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1080\/21645515.2016.1197454","article-title":"A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis","volume":"12","author":"Griffiths","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2026.07.058_bib8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.058_bib9","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final Analysis of a Trial of M72\/AS01(E) Vaccine to Prevent Tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.058_bib10","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.ymthe.2026.07.029","article-title":"Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis","volume":"34","author":"Parzych","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.058_bib11","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1016\/j.cell.2025.08.027","article-title":"Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines","volume":"188","author":"Vidal","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.058_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","article-title":"Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India","volume":"399","author":"Khobragade","year":"2022","journal-title":"Lancet"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626006817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:34:53Z","timestamp":1793374493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626006817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525001626006817"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.058","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A renewed role for DNA vaccines for tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}